Covered recipient · General Payments record
NATALYA KOZLOVA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$607.24
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.74 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Shionogi Inc | $109.65 | 1 |
| Acerta Pharma LLC | $81.90 | 2 |
| ABBVIE INC. | $49.86 | 3 |
| Merck Sharp & Dohme Corporation | $45.59 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.51 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104105940 | CMS |
| ABBVIE INC. | $17.68 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104105942 | CMS |
| ABBVIE INC. | $18.67 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104105944 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.11 | 08/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104333520 | CMS |
| AstraZeneca Pharmaceuticals LP | $66.79 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104488974 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.74 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118077334 | CMS |
| Merck Sharp & Dohme LLC | $15.07 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141914213 | CMS |
| Merck Sharp & Dohme LLC | $13.67 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141588434 | CMS |
| Merck Sharp & Dohme LLC | $16.85 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141832941 | CMS |
| Shionogi Inc | $109.65 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154335798 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.